Willemsen, S., Hartog, J., van Veldhuisen, D., van der Meer, P., Roze, J., Jaarsma, T., Schalkwijk, C., van der Horst, I., Hillege, H. & Voors, A. (2012). The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction. American Heart Journal,164(5), 742-749. Retrieved from https://doi.org/10.1016/j.ahj.2012.07.027
Introduction: Advanced glycation end products (AGEs) are increased in patients with heart failure (HF). We studied the predictive value of plasma AGEs Nε-(carboxymethyl)lysine (CML), pentosidine, and the soluble form of its receptor (sRAGE) in a large HF population.
Mary MacKillop Institute for Health Research
Access may be restricted.